CLINICAL_TRIALS
trial_result
· 2008-04-01
Clinical Trial Update: Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy [Phase 2]
Summary
Pfizer conducted a Phase 2 clinical trial of intravenous edotecarin in patients with advanced gastric cancer that progressed after chemotherapy; the study is co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED